Chronicle Journal: Finance

Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
Glaxosmithkline Plc (NY: GSK)
41.92 USD  +0.38 (+0.91%)
Official Closing Price  /  Updated: 7:59 PM EDT, May 29, 2020  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 3,696,300
Open 41.79
Bid (Size) 41.92 (2)
Ask (Size) 42.00 (3)
Prev. Close 41.54
Today's Range 41.08 - 41.96
52wk Range 31.43 - 48.25
Shares Outstanding 2,479,760,852
Dividend Yield 5.10%
Performance
YTD
-10.66%
-10.66%
1 Month
+0.17%
+0.17%
3 Month
+3.43%
+3.43%
6 Month
-7.83%
-7.83%
1 Year
+8.21%
+8.21%
Top News
More News
Clinical Studies & Research Progressing For Finding Cure For Glioblastoma
category Featured News
from FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
Clinical Studies & Research Progressing for Finding Cure for Glioblastoma
Financialnewsmedia.com News Commentary Read More
from PR Newswire
More News
Read More
GSK partners with Samsung Biologics to secure additional manufacturing capacity for innovative biopharmaceutical portfolio
from PR Newswire
PRESS DIGEST-Financial Times - May 29
category companyNews
from Reuters: Company News
UPDATE 2-European stocks rise for fourth day on healthcare bounce
category companyNews
from Reuters: Company News
UPDATE 3-GSK aims for 1 bln doses of booster as COVID-19 vaccine race heats up
category companyNews
from Reuters: Company News
GlaxoSmithKline Plans to Produce 1 Billion Doses of Its Pandemic Vaccine Adjuvant in 2021
category MRNA , GSK , Market News
from Motley Fool
UPDATE 2-GSK aims for 1 bln doses with COVID vaccine booster plan
category companyNews
from Reuters: Company News
RPT-UPDATE 1-Wall St Week Ahead-Investors look beyond drug makers as hunt for Covid-19 treatment heats up
category companyNews
from Reuters: Company News
Race for Coronavirus Vaccine Heats Up: Biotech ETFs to Gain
category Pharma/Biotech , ETFs
from Blogs - TalkMarkets
At Last, Merck Is Diving Into Coronavirus Vaccine and Antiviral Development
category AZN , Market News , MRK , and 2 more.
from Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

© Copyright 2015, Chronicle Journal, Thunder Bay, ON. Powered by BLOX Content Management System from TownNews.com. [Terms of Use | Privacy Policy]